Journal profile · SUBSTANCE ABUSE
Drugs Education Prevention and Policy
ISSN 0968-7637 · eISSN 1465-3370 · Taylor & Francis
Drugs Education Prevention and Policy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.36; JCR Q2 (journal website); hybrid open access; APC about USD 3,450; median 154 days to acceptance (97 articles, last 24 months); acceptance rate 26% (journal website); 65 articles in 2025; indexed in SSCI and Scopus.
Scope
Aims, scope and focus
Drugs Education Prevention and Policy is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, HIV, Drug Use, Sexual Risk and Homelessness and Social Issues, together about 45.2% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
Drugs: education, prevention & policy publishes multi-disciplinary research papers, reviews and commentaries on policy, treatment, prevention and harm reduction issues regarding both the use and misuse of alcohol, tobacco and other drugs. The policy of the journal is to encourage submissions which reflect different cultural, historical and theoretical approaches to the understanding of the drug and alcohol field and the development of policy and practice. The journal provides a forum for communication and debate between researchers, policy makers and practitioners concerned with social, health and judicial policy responses to legal and illicit drug use. The Editor welcomes contributions based on original research, policy discussion, social responses to substance use or misuse, co-evaluations of policy and practice, literature reviews, and finally those papers which examine historical and cultural aspects of substance use. The journal operates a double-anonymized peer review policy.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE
Editor-in-chief Torsten KolindPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine24.7%
- HIV, Drug Use, Sexual RiskMedicine10.3%
- Homelessness and Social IssuesHealth Professions10.2%
- Opioid Use Disorder TreatmentMedicine6%
- Cannabis and Cannabinoid ResearchMedicine4.6%
- Community Health and DevelopmentHealth Professions4.6%
- Health Policy Implementation ScienceHealth Professions4.3%
- Mental Health and Patient InvolvementHealth Professions4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Sociology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Sociology | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PsycINFOCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.36LetPub ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 4.5LetPub ·
- CiteScore (publisher) 2025
- 4.5Publisher website ·
- SJR 2026-06
- 0.67LetPub ·
- SJR (publisher) 2025
- 0.67Publisher website ·
- SNIP 2026-06
- 0.91LetPub ·
- SNIP (publisher) 2025
- 0.91Publisher website ·
- h-index
- 65OpenAlex ·
- i10-index
- 734OpenAlex ·
- 2-year mean citedness
- 1.86OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 37.57%LetPub ·
Volume
- Articles per year
- 61LetPub ·
- Downloads per year (publisher)
- 283,000Publisher website ·
Articles by year OpenAlex count · 1,921 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 38 | 7 |
| 2025 | 65 | 38 | 74 |
| 2024 | 68 | 49 | 278 |
| 2023 | 62 | 40 | 362 |
| 2022 | 70 | 42 | 543 |
| 2021 | 89 | 55 | 996 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
154 daysMedian, submission to acceptance · P25–P75 103 days – 196 days
- Acceptance to online
- median 12 days (98 articles)
- Submission to online
- median 166 days
- Sample
- 97 articles with submission and acceptance dates (144 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 26%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 58 daysPublisher website ·
- Acceptance to publication
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 3,450 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- research articleResearch Article | Published online: 16 Sep 2026Length not stated
- reviewpublishes multi-disciplinary research papers, reviews and commentariesLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Drugs: Education, Prevention and Policy is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the dis…
Source ↗Publisher website ·- Peer review
Double-anonymized peer review Model summary
The journal operates a double-anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 0968-7637
- Electronic ISSN
- 1465-3370
- Latest issue on the website
- Volume 33, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Drugs Education Prevention and Policy
What CAS zone is Drugs Education Prevention and Policy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drugs Education Prevention and Policy is in Zone 4 of Medicine, and in Zone 4 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drugs Education Prevention and Policy?
The latest impact factor listed by LetPub is 2.36; CiteScore 4.5, h-index 65.
How long does peer review take at Drugs Education Prevention and Policy?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 154 days (interquartile range 103–196 days); the journal's website gives an acceptance rate of 26%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Drugs Education Prevention and Policy in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Drugs Education Prevention and Policy?
According to LetPub and DOAJ records, Drugs Education Prevention and Policy is indexed in SSCI and Scopus. The journal's website also lists PsycINFO and Current Contents; that list has not been checked against each database.
Is Drugs Education Prevention and Policy open access, and what is the APC?
Drugs Education Prevention and Policy is a hybrid journal. For open-access publication: APC about USD 3,450.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .